Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel Wilson

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
The New Zealand Medical Journal|May 20, 2021
Acute rheumatic fever-a preventable, inequitable disease: a call for actionJulie Bennett, Anneka Anderson, Malakai 'Ofanoa, et al.
The Lancet Regional Health. Western Pacific|October 10, 2022
Risk factors for acute rheumatic fever: A case-control studyMichael G Baker, Jason Gurney, Nicole J Moreland, et al.
BMJ Open|September 16, 2021
Searching for a technology-driven acute rheumatic fever test: the START study protocolAnna P Ralph, Rachel Webb, Nicole J Moreland, et al.
Frontiers in Immunology|August 2, 2021
Mapping Autoantibodies in Children With Acute Rheumatic FeverReuben McGregor, Mei Lin Tay, Lauren H Carlton, et al.
International Journal of Environmental Research and Public Health|November 17, 2019
Risk Factors for Acute Rheumatic Fever: Literature Review and Protocol for a Case-Control Study in New ZealandMichael G Baker, Jason Gurney, Jane Oliver, et al.
Nature Reviews. Cardiology|February 29, 2012
World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease--an evidence-based guidelineBo Reményi, Nigel Wilson, Andrew Steer, et al.
Circulation|June 12, 2023
Refining Risk Stratification Among Children With Latent Rheumatic Heart DiseaseAndrea Beaton, Emmy Okello, Joselyn Rwebembera, et al.
The New England Journal of Medicine|November 12, 2021
Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart DiseaseAndrea Beaton, Emmy Okello, Joselyn Rwebembera, et al.
Circulation|September 15, 2025
Short-Course Secondary Antibiotic Prophylaxis for Children With Screen-Detected Mild Rheumatic Heart DiseaseJoselyn Rwebembera, Craig Sable, Anneke C Grobler, et al.
Journal of the American Heart Association|January 14, 2026
With Antibiotic Prophylaxis, Mild Rheumatic Heart Disease Rarely Progresses Over 5 YearsJoselyn Rwebembera, Craig Sable, Anneke C Grobler, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
The New Zealand Medical Journal|May 20, 2021
Acute rheumatic fever-a preventable, inequitable disease: a call for actionJulie Bennett, Anneka Anderson, Malakai 'Ofanoa, et al.
The Lancet Regional Health. Western Pacific|October 10, 2022
Risk factors for acute rheumatic fever: A case-control studyMichael G Baker, Jason Gurney, Nicole J Moreland, et al.
BMJ Open|September 16, 2021
Searching for a technology-driven acute rheumatic fever test: the START study protocolAnna P Ralph, Rachel Webb, Nicole J Moreland, et al.
Frontiers in Immunology|August 2, 2021
Mapping Autoantibodies in Children With Acute Rheumatic FeverReuben McGregor, Mei Lin Tay, Lauren H Carlton, et al.
International Journal of Environmental Research and Public Health|November 17, 2019
Risk Factors for Acute Rheumatic Fever: Literature Review and Protocol for a Case-Control Study in New ZealandMichael G Baker, Jason Gurney, Jane Oliver, et al.
Nature Reviews. Cardiology|February 29, 2012
World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease--an evidence-based guidelineBo Reményi, Nigel Wilson, Andrew Steer, et al.
Circulation|June 12, 2023
Refining Risk Stratification Among Children With Latent Rheumatic Heart DiseaseAndrea Beaton, Emmy Okello, Joselyn Rwebembera, et al.
The New England Journal of Medicine|November 12, 2021
Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart DiseaseAndrea Beaton, Emmy Okello, Joselyn Rwebembera, et al.
Circulation|September 15, 2025
Short-Course Secondary Antibiotic Prophylaxis for Children With Screen-Detected Mild Rheumatic Heart DiseaseJoselyn Rwebembera, Craig Sable, Anneke C Grobler, et al.
Journal of the American Heart Association|January 14, 2026
With Antibiotic Prophylaxis, Mild Rheumatic Heart Disease Rarely Progresses Over 5 YearsJoselyn Rwebembera, Craig Sable, Anneke C Grobler, et al.
Pageof 7